Sex Reassignment Surgery For Transgenders: Should It Be Covered By Health Insurance?

People who identify themselves as transgender evolved in their belief of a gender-assignment mistake when they are self-aware of stereotypes involving genders, which can occur as early as the age of three years old. This sense of identity can adversely… Continue Reading

Paying for Specialty Pharmaceuticals: The Case of Injectable Oncology Drugs

According to the American Cancer Society, the financial costs of cancer are high for both the person with cancer and for society as a whole. The National Institutes of Health (NIH) estimated the 2009 overall annual costs of cancer in… Continue Reading

Removing Bias from HEOR: Standardizing the Costs of Adverse Events

What are the total costs of prescribing a particular drug? At its core, all health economics and outcomes research (HEOR) studies are designed to answer this fundamental question. And it is this answer that helps to remove barriers to market… Continue Reading

WHEN 1+1=3: HOW ELECTRONIC HEALTH RECORDS AND CLAIMS CAN BE USED SYNERGISTICALLY

Sponsored blog posting by DaVita Clinical Research. 1. Combining Drug Development with Real-World Data Analytics DaVita Clinical Research® (DCR®), a specialty full-service contract research organization, recently merged with HealthCare Partners Clinical Research to further expand its clinical research and data… Continue Reading